AU2003300815A1 - Protein modification and maintenance molecules - Google Patents
Protein modification and maintenance moleculesInfo
- Publication number
- AU2003300815A1 AU2003300815A1 AU2003300815A AU2003300815A AU2003300815A1 AU 2003300815 A1 AU2003300815 A1 AU 2003300815A1 AU 2003300815 A AU2003300815 A AU 2003300815A AU 2003300815 A AU2003300815 A AU 2003300815A AU 2003300815 A1 AU2003300815 A1 AU 2003300815A1
- Authority
- AU
- Australia
- Prior art keywords
- protein modification
- maintenance molecules
- molecules
- maintenance
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US43163902P | 2002-12-05 | 2002-12-05 | |
US60/431,639 | 2002-12-05 | ||
US43431502P | 2002-12-17 | 2002-12-17 | |
US60/434,315 | 2002-12-17 | ||
US44244203P | 2003-01-24 | 2003-01-24 | |
US60/442,442 | 2003-01-24 | ||
US44414103P | 2003-01-30 | 2003-01-30 | |
US60/444,141 | 2003-01-30 | ||
US44949103P | 2003-02-21 | 2003-02-21 | |
US60/449,491 | 2003-02-21 | ||
PCT/US2003/038573 WO2004053068A2 (fr) | 2002-12-05 | 2003-12-03 | Molecules de modification et de maintenance de proteines |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2003300815A1 true AU2003300815A1 (en) | 2004-06-30 |
AU2003300815A8 AU2003300815A8 (en) | 2004-06-30 |
Family
ID=32512689
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003300815A Abandoned AU2003300815A1 (en) | 2002-12-05 | 2003-12-03 | Protein modification and maintenance molecules |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003300815A1 (fr) |
WO (1) | WO2004053068A2 (fr) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005090569A1 (fr) * | 2004-03-24 | 2005-09-29 | The Council Of The Queensland Institute Of Medical Research | Cancer et acides nucleiques et proteines de testicule vsm1 et vsm2, et leurs utilisations |
CA2590751A1 (fr) | 2004-12-13 | 2006-06-22 | Roy Rabindranauth Sooknanan | Sequences polynucleotidiques et polypeptidiques participant au remodelage osseux |
WO2007147496A1 (fr) * | 2006-06-17 | 2007-12-27 | Bayer Healthcare Ag | Utilisation de la n-acylaminoacylpeptide hydrolase (apeh) comme cible thérapeutique ou diagnostique |
JP2010507387A (ja) | 2006-10-25 | 2010-03-11 | クアーク・ファーマスーティカルス、インコーポレイテッド | 新規のsiRNAおよびその使用方法 |
CA3028975A1 (fr) | 2016-06-20 | 2017-12-28 | Healthtell Inc. | Methodes pour le diagnostic et le traitement de maladies auto-immunes |
WO2017223116A2 (fr) | 2016-06-20 | 2017-12-28 | Healthtell Inc. | Procédés pour le diagnostic différentiel de maladies auto-immunes |
WO2018089556A1 (fr) | 2016-11-09 | 2018-05-17 | Healthtell Inc. | Revêtements à densité d'amine réglable |
WO2018089858A1 (fr) | 2016-11-11 | 2018-05-17 | Healthtell Inc. | Procédés pour l'identification de biomarqueurs candidats |
EP3642233A4 (fr) * | 2017-06-19 | 2021-08-11 | Healthtell Inc. | Immunosignatures pour diagnostic différentiel |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2001241541A1 (en) * | 2000-02-17 | 2001-08-27 | Millennium Predictive Medicine, Inc. | Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of human prostate cancer |
US20030108963A1 (en) * | 2001-07-25 | 2003-06-12 | Millennium Pharmaceuticals, Inc. | Novel genes, compositions, kit, and methods for identification, assessment, prevention and therapy of prostate cancer |
-
2003
- 2003-12-03 AU AU2003300815A patent/AU2003300815A1/en not_active Abandoned
- 2003-12-03 WO PCT/US2003/038573 patent/WO2004053068A2/fr not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2004053068A2 (fr) | 2004-06-24 |
WO2004053068A3 (fr) | 2005-04-21 |
AU2003300815A8 (en) | 2004-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002227280A1 (en) | Protein modification and maintenance molecules | |
AU2002950303A0 (en) | Improvements in assembly and disassembly | |
AU2002258388A1 (en) | Narc8 programmed cell-death-associated molecules and uses thereof | |
AU2002318356A1 (en) | Protein modification and maintenance molecules | |
AU2001270271A1 (en) | Protein modification and maintenance molecules | |
AU2003300815A1 (en) | Protein modification and maintenance molecules | |
AU2003205353A1 (en) | Protein modification and maintenance molecules | |
AU2003268023A1 (en) | Protein modification and maintenance molecules | |
AU2002253883A1 (en) | Protein modification and maintenance molecules | |
EP1572168A3 (fr) | Molecules anti-infarcissement | |
AUPS187002A0 (en) | Condition-specific molecules and uses therefor | |
AU2003239871A1 (en) | Protein modification and maintenance molecules | |
AU2002343515A1 (en) | Protein modification and maintenance molecules | |
AU2003231981A1 (en) | Protein modification and maintenance molecules | |
AU2002953223A0 (en) | Novel therapeutic molecules and uses thereof | |
AU2003235096A1 (en) | Novel protein and dna thereof | |
AU2002336529A1 (en) | Protein modification and maintenance molecules | |
AU2002258724A1 (en) | Protein modification and maintenance molecules | |
AU2003236374A1 (en) | Atopic dermatitis-inducing proteins | |
AU2003298589A1 (en) | Protein modification and maintenance molecules | |
AU2003279829A1 (en) | Protein modification and maintenance molecules | |
AU2003280992A1 (en) | Novel proteins and use thereof | |
AU2003219732A1 (en) | Oligomeric molecules and uses thereof | |
AU2003292721A1 (en) | Novel protein and its gene | |
AU2003262080A1 (en) | Novel protein and dna thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |